A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A pilot randomized controlled trial will be conducted to investigate the feasibility and effectiveness of a salt intake reduction intervention to young hypertension patients in Hong Kong who had high salt intake.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using Night-time Blood Pressure to Treat Hypertension

NCT05031637

Hypertension

COMPLETED NA

China Salt Substitute Study in Tibet

NCT01429246

Hypertension

COMPLETED NA

Therapeutic Effect of Sodium Intake Reduction in Treatment Resistant Hypertension

NCT03424317

Sodium Intake Resistant Hypertension

TERMINATED NA

Tibet Salt Reduction Study

NCT02021435

Blood Pressure Cardiovascular Diseases Death

UNKNOWN NA

Pilot to Examine Risk and Feasibility of Remote Management of BP From Childhood Into Early Adulthood

NCT03691701

Chronic Kidney Diseases Hypertension Blood Pressure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Convenience sample will be recruited from the community in Hong Kong through different channels of promotion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Four-week weekly intervention to reduce salt intake.

Group Type EXPERIMENTAL

Four-week weekly intervention to reduce salt intake

Intervention Type BEHAVIORAL

The intervention group will receive a four-week weekly intervention, about 15 minutes each. Two sessions will be face-to-face and two sessions will be on the phone. The participants will be informed of their 24-hour urinary sodium excretion at each measurement time once available.

Control group

Usual government pamphlets.

Group Type OTHER

Usual government pamphlets

Intervention Type OTHER

The control group will receive usual government pamphlets when they know their 24-hour urinary sodium excretion at baseline. However, they will not be informed of their follow-up urinary sodium excretion results immediately.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Four-week weekly intervention to reduce salt intake

The intervention group will receive a four-week weekly intervention, about 15 minutes each. Two sessions will be face-to-face and two sessions will be on the phone. The participants will be informed of their 24-hour urinary sodium excretion at each measurement time once available.

Intervention Type BEHAVIORAL

Usual government pamphlets

The control group will receive usual government pamphlets when they know their 24-hour urinary sodium excretion at baseline. However, they will not be informed of their follow-up urinary sodium excretion results immediately.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* i) adults aged 18 to 44
* ii) diagnosed hypertension or borderline hypertension
* iii) complete collection of 24-hour urine at baseline
* iv) 24-hour urinary sodium excretion above 2000mg at baseline
* v) can communicate in Cantonese

Exclusion Criteria

* i) renal illnesses;
* ii) taking diuretics;
* iii) taking RAS blockers;
* iv) attending or planning to attend new hypertension education programme or salt intake reduction programme during the study period.

Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No